Molecular Biology

News

Anthropic puts life sciences at heart of new AI model

Anthropic has released Claude Fable 5, trumpeting its R&D credentials, but has faced a backlash over "safeguards" built into the model.

News

Caris swells its planned IPO, seeking $5.7bn valuation

AI-powered techbio firm Caris Life Sciences has raised the target price for its IPO, pointing to strong demand among investors.

Digital

Close up of lab assistant in uniform, with mask and rubber gloves holding test tube with blood sample while sitting on chair and typing on laptop. Selective focus on test tubes.

The future of AI drug discovery & development in immunology ...

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares.

Anthropic puts life sciences at heart of new AI model

Caris swells its planned IPO, seeking $5.7bn valuation

The future of AI drug discovery & development in immunology ...

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks